Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.1.6.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.28EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.7EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
P.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19092.4South Korea
P.2 (Zeta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
P.2 (Zeta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.27EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.7.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.26EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.8EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CM.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.27EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.1.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.16EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.28EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DG.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
DG.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.56EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.56EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.2.13EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
KP.2.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDP.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XDP.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HN.8EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HN.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DE.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
DE.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.333EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.333EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.6.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CM.6.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.54EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.54EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DR.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
DR.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.3.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.3.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
ED.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
ED.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CM.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CA.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used